基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 生物化工 抑制剂 PI3K/Akt/mTOR抑制剂(PI3K/Akt/mTOR) mTOR 抑制剂 咗他莫司 佐他莫司
  • 佐他莫司|T6033|TargetMol

佐他莫司|T6033|TargetMol

Zotarolimus
221877-54-9
553 1mg 起订
793 2mg 起订
1230 5mg 起订
上海 更新日期:2024-12-12

TargetMol中国(陶术生物)

VIP3年
联系人:邵小姐
手机:4008200310 拨打
邮箱:marketing@tsbiochem.com

产品详情:

中文名称:
佐他莫司
英文名称:
Zotarolimus
CAS号:
221877-54-9
品牌:
TargetMol
产地:
美国
保存条件:
Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
纯度规格:
≥98%
产品类别:
抑制剂
货号:
T6033

Product Introduction

Bioactivity

名称Zotarolimus
描述Zotarolimus (ABT-578), an analogue of rapamycin, inhibits FKBP-12 (IC50= 2.8 nM).
细胞实验Cell proliferation is assayed by measuring tritiated thymidine incorporation in vitro. Human coronary artery cells (hCa) are seeded into tissue culture flasks for expansion and applied to 96-well plates at desired density in complete media (5000 hCaSMC; 10 000 hCaEC). After 2 days, complete media is replaced with incomplete media to synchronize cells and induce G0 state. Two days later, incomplete media are removed and replaced with complete media (serum/growth factors) to induce G0 to G1 transition. Complete media also contain drug at desired concentrations to determine its effects on cell proliferation. On day 7, 3H-thymidine is added to cells to monitor DNA synthesis, and cells are harvested after overnight incorporation of radioactivity. After an incubation period of 72 h, 25 μL (1 μCi/well) of 3H-thymidine are added to each well. The cells are incubated at 37°C for 16-18 h to allow for incorporation of 3H-thymidine into newly synthesized DNA and the cells harvested onto 96-well plates containing bonded glass fibre filters . The filter plates are air-dried overnight, MicroScint-20 (25 μL) added to each filter well and counted. Drug activity is determined by the inhibition of 3H-thymidine incorporation into newly synthesized DNA relative to cells grown in complete media. (Only for Reference)
激酶实验zotarolimus (10 pM-1 μM) in buffer A (2% BSA and 0.2% Tween-20 in D-PBS) is used in the assay of Binding Affinity to FKBP12.
动物实验Male Sprague-Dawley rats was administrate by intravenous or oral Zotarolimus(2.5 mg/kg)dissolved inethanol: propylene glycol: cremophor EL: D5W vehicle (20: 30: 2: 48, by volume).
体外活性在平滑肌细胞(IC50=2.9 nM)和内皮细胞(IC50=2.6 nM)中,Zotarolimus有效抑制细胞增殖。
体内活性Zotarolimus 强效抑制剂,对辅助性迟发型超敏反应(DTH)(ED50=1.72 mg/kg/day)、实验性自身免疫性脑炎(EAE)(ED50=1.17 mg/kg/day)、以及心脏移植排斥反应(ED50=3.71 mg/kg/day)表现出显著的抑制作用。
存储条件Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
溶解度Ethanol : 93 mg/mL (96.3 mM)
DMSO : 93 mg/mL (96.3 mM)
H2O : < 1 mg/mL (insoluble or slightly soluble)
关键字coronary | ABT 578 | drug-eluting | inhibit | artery | disease | restenosis | Rapamycin | Zotarolimus | ABT578 | immunosuppressant | A-179578 | stents | A179578 | Inhibitor
相关产品α-Hydroxyglutaric Acid Lithium | P-2281 | Capivasertib | Rapamycin | Bimiralisib | L-Leucine | GDC0084 | Tacrolimus | Dihydromyricetin | PI3K/Akt/mTOR-IN-2 | Sapanisertib | (+)-Usnic acid
相关库经典已知活性库 | 已知活性化合物库 | 激酶抑制剂库 | 抗衰老化合物库 | 药物功能重定位化合物库 | 抗癌临床化合物库 | 抗癌药物库
咗他莫司|||佐他莫司|||ABT-578|||A 179578|TargetMol

公司简介

TargetMol Chemicals Inc. 总部位于马萨诸塞州波士顿,致力于为全球生化领域科学家的研究提供专业的产品和服务。TargetMol?品牌的客户群分布于40多个国家和地区,已发展成为全球知名的化合物库和小分子化合物研究供应商。 TargetMol?可提供160多种满足不同需求的化合物库,以及多种类型的生化试剂产品,包括12000多种抑制剂、16000多种天然产物和各类多肽、抗体、生命科学试剂盒等,此外,我们还建设有CADD(计算机辅助药物设计)研究中心、药理实验室、药化合成平台三大技术中心,全方位满足客户的定制需求。 凭借我们优质的产品和服务、快速高效的全球供应链和专业的技术支持,我们将有效帮助您缩短研发周期,取得更成功的结果。

成立日期 (12年)
注册资本 566.265100万人民币
员工人数 100-500人
年营业额 ¥ 1亿以上
经营模式 贸易,工厂,试剂,定制,服务
主营行业 天然产物,生化试剂,分子生物学,分子砌块,生物技术服务

佐他莫司相关厂家报价

  • 佐他莫司
  • 佐他莫司
  • 湖北威德利化学试剂有限公司 VIP
  • 2024-12-18
  • ¥16000
  • Zotarolimus
  • Zotarolimus
  • 南京百鑫德诺生物科技有限公司
  • 2024-09-26
  • 询价
内容声明
拨打电话 立即询价